Effectiveness of Oseltamivir in Hospitalized Children With Laboratory-Confirmed Influenza, 2014-2023
Oseltamivir treatment was found to decrease both the likelihood of ICU admission and hospital length of stay among pediatric patients hospitalized with laboratory-confirmed influenza.
Trends in childhood vaccination coverage in the European Union, 1980–2024: an ecological time-series study
Despite long-term gains, recent EU-wide coverage declines signal increasing risks to herd and individual immunity.
WHO prequalifies multi-dose RSV vaccine vial, paving the way to protecting more infants globally
The WHO has prequalified the multi-dose vial presentation of the maternal respiratory syncytial virus (RSV) vaccine, RSVpreF (ABRYSVO®).
Article
News
In the media
Policy & Recommendations
#IDCBreathAndBeyond calls for respiratory virus prevention to be fully integrated into NCD care
Campaign led by the ESWI IDC, calling for better prevention, better care, better protection for people living with chronic diseases
(Recording available) IDC Partner Session at WOHC2026 - Exploring bidirectional links between respiratory viruses & non-communicable diseases
Now available to watch On Demand - IDC session at 9th World One Health Congress in Lisbon, 6 September 2026.
Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants
maternal RSVpreF vaccination was associated with 78% to 81% reduction in RSV-associated hospitalization from birth through 6 months of age, with the highest vaccine effectiveness in earliest age intervals.
Immunogenicity and safety of recombinant influenza vaccine versus standard inactivated influenza vaccine in children aged 3 to 8 years: results from a phase III randomised study
Participants aged 3–8 years were randomised in a 1:1 ratio to receive the quadrivalent recombinant influenza vaccine (RIV4) or quadrivalent inactivated influenza vaccine (IIV4).
Influenza Vaccine Effectiveness in School Outbreaks During a A(H3N2) Subclade K (J.2.4.1)-Dominated Season in Beijing, China, 2025–26
Vaccination provided protection despite intense transmission settings